Lista de obras -

Activation of Nrf2 might reduce oxidative stress in human granulosa cells

artículo científico publicado en 2017

Activation of Nrf2/Keap1 pathway by oral Dimethylfumarate administration alleviates oxidative stress and age-associated infertility might be delayed in the mouse ovary

article

Anti-Tumor Effect of Inhibition of DNA Damage Response Proteins, ATM and ATR, in Endometrial Cancer Cells

scientific article published on 01 December 2019

Anti-tumor activity of dual inhibition of phosphatidylinositol 3-kinase and MDM2 against clear cell ovarian carcinoma

scientific article published on 05 September 2019

Antitumor activity and induction of TP53-dependent apoptosis toward ovarian clear cell adenocarcinoma by the dual PI3K/mTOR inhibitor DS-7423.

scientific article published on 04 February 2014

Autophagy inhibition augments resveratrol-induced apoptosis in Ishikawa endometrial cancer cells.

artículo científico publicado en 2016

Blood Vessel Invasion Is a Strong Predictor of Postoperative Recurrence in Endometrial Cancer

artículo científico publicado en 2018

CCAR2 negatively regulates nuclear receptor LXRα by competing with SIRT1 deacetylase

artículo científico publicado en 2015

Correction: Integrated Copy Number and Expression Analysis Identifies Profiles of Whole-Arm Chromosomal Alterations and Subgroups with Favorable Outcome in Ovarian Clear Cell Carcinomas

artículo científico publicado en 2015

Cyclin D1 harboring the T286I mutation promotes oncogenic activation in endometrial cancer.

artículo científico publicado en 2013

Desensitization strategy for hypersensitivity reactions to carboplatin in five patients with gynecological cancer

scientific article published on 23 August 2020

Effect of MDM2 inhibitors in preclinical models of advanced clear cell carcinomas originating from ovaries and kidneys

artículo científico publicado en 2020

Epigenetic Modifier SETD8 as a Therapeutic Target for High-Grade Serous Ovarian Cancer

artículo científico publicado en 2020

Expression of DBC1 is associated with nuclear grade and HER2 expression in breast cancer.

artículo científico publicado en 2011

Genotype-dependent efficacy of a dual PI3K/mTOR inhibitor, NVP-BEZ235, and an mTOR inhibitor, RAD001, in endometrial carcinomas

artículo científico publicado en 2012

HAND2-mediated proteolysis negatively regulates the function of estrogen receptor α.

artículo científico publicado en 2015

Histone methyltransferase SMYD2 selective inhibitor LLY-507 in combination with poly ADP ribose polymerase inhibitor has therapeutic potential against high-grade serous ovarian carcinomas

artículo científico publicado en 2019

Integrated copy number and expression analysis identifies profiles of whole-arm chromosomal alterations and subgroups with favorable outcome in ovarian clear cell carcinomas

artículo científico publicado en 2015

Interleukin-17 is associated with expression of programmed cell death 1 ligand 1 in ovarian carcinoma

scientific article published on 24 September 2019

Kaempferol, a natural dietary flavonoid, suppresses 17β-estradiol-induced survivin expression and causes apoptotic cell death in endometrial cancer

Measurement of endometrial thickness by transvaginal ultrasonography to predict pathological response to medroxyprogesterone acetate in patients with grade 1 endometrioid adenocarcinoma

artículo científico publicado en 2016

Oncogenic histone methyltransferase EZH2: A novel prognostic marker with therapeutic potential in endometrial cancer

artículo científico publicado en 2017

PI3K/mTOR pathway inhibition overcomes radioresistance via suppression of the HIF1-α/VEGF pathway in endometrial cancer.

artículo científico publicado en 2015

Polycystic Ovarian Morphology may be a Positive Prognostic Factor in Patients with Endometrial Cancer who Achieved Complete Remission after Fertility-Sparing Therapy with Progestin

artículo científico publicado en 2017

Positive peritoneal cytology at interval surgery is a poor prognostic factor in patients with stage T3c advanced ovarian carcinoma: A retrospective study

artículo científico publicado en 2014

Putative tumor suppression function of SIRT6 in endometrial cancer

artículo científico publicado en 2015

Radical hysterectomy with or without para-aortic lymphadenectomy for patients with stage IB2, IIA2, and IIB cervical cancer: outcomes for a series of 308 patients

artículo científico publicado en 2015

Recent advances in targeting DNA repair pathways for the treatment of ovarian cancer and their clinical relevance

artículo científico publicado en 2017

Regulation of SIRT1 determines initial step of endometrial receptivity by controlling E-cadherin expression

artículo científico publicado en 2012

Repression of estrogen receptor beta function by putative tumor suppressor DBC1

artículo científico publicado en 2010

Sequential effects of the proteasome inhibitor bortezomib and chemotherapeutic agents in uterine cervical cancer cell lines

artículo científico publicado en 2012

The Emerging Role of FOXL2 in Regulating the Transcriptional Activation Function of Estrogen Receptor β: An Insight Into Ovarian Folliculogenesis.

artículo científico publicado en 2016

The anti-malarial chloroquine suppresses proliferation and overcomes cisplatin resistance of endometrial cancer cells via autophagy inhibition.

artículo científico publicado en 2015

The histone methyltransferase SMYD2 is a novel therapeutic target for the induction of apoptosis in ovarian clear cell carcinoma cells

scientific article published on 24 August 2020

The histone methyltransferase WHSC1 is regulated by EZH2 and is important for ovarian clear cell carcinoma cell proliferation

artículo científico publicado en 2019

Usefulness of biopsy by office hysteroscopy for endometrial cancer: A case report

scientific article published on 27 May 2020

Usefulness of cell-free and concentrated ascites reinfusion therapy in the therapeutic management of advanced ovarian cancer patients with massive ascites

artículo científico publicado en 2018

Lista de obras de

Activation of Nrf2 might reduce oxidative stress in human granulosa cells

Activation of Nrf2/Keap1 pathway by oral Dimethylfumarate administration alleviates oxidative stress and age-associated infertility might be delayed in the mouse ovary

Anti-Tumor Effect of Inhibition of DNA Damage Response Proteins, ATM and ATR, in Endometrial Cancer Cells

Anti-tumor activity of dual inhibition of phosphatidylinositol 3-kinase and MDM2 against clear cell ovarian carcinoma

Antitumor activity and induction of TP53-dependent apoptosis toward ovarian clear cell adenocarcinoma by the dual PI3K/mTOR inhibitor DS-7423.

Autophagy inhibition augments resveratrol-induced apoptosis in Ishikawa endometrial cancer cells.

Blood Vessel Invasion Is a Strong Predictor of Postoperative Recurrence in Endometrial Cancer

CCAR2 negatively regulates nuclear receptor LXRα by competing with SIRT1 deacetylase

Correction: Integrated Copy Number and Expression Analysis Identifies Profiles of Whole-Arm Chromosomal Alterations and Subgroups with Favorable Outcome in Ovarian Clear Cell Carcinomas

Cyclin D1 harboring the T286I mutation promotes oncogenic activation in endometrial cancer.

Desensitization strategy for hypersensitivity reactions to carboplatin in five patients with gynecological cancer

Effect of MDM2 inhibitors in preclinical models of advanced clear cell carcinomas originating from ovaries and kidneys

Epigenetic Modifier SETD8 as a Therapeutic Target for High-Grade Serous Ovarian Cancer

Expression of DBC1 is associated with nuclear grade and HER2 expression in breast cancer.

Genotype-dependent efficacy of a dual PI3K/mTOR inhibitor, NVP-BEZ235, and an mTOR inhibitor, RAD001, in endometrial carcinomas

HAND2-mediated proteolysis negatively regulates the function of estrogen receptor α.

Histone methyltransferase SMYD2 selective inhibitor LLY-507 in combination with poly ADP ribose polymerase inhibitor has therapeutic potential against high-grade serous ovarian carcinomas

Integrated copy number and expression analysis identifies profiles of whole-arm chromosomal alterations and subgroups with favorable outcome in ovarian clear cell carcinomas

Interleukin-17 is associated with expression of programmed cell death 1 ligand 1 in ovarian carcinoma

Kaempferol, a natural dietary flavonoid, suppresses 17β-estradiol-induced survivin expression and causes apoptotic cell death in endometrial cancer

Measurement of endometrial thickness by transvaginal ultrasonography to predict pathological response to medroxyprogesterone acetate in patients with grade 1 endometrioid adenocarcinoma

Oncogenic histone methyltransferase EZH2: A novel prognostic marker with therapeutic potential in endometrial cancer

PI3K/mTOR pathway inhibition overcomes radioresistance via suppression of the HIF1-α/VEGF pathway in endometrial cancer.

Polycystic Ovarian Morphology may be a Positive Prognostic Factor in Patients with Endometrial Cancer who Achieved Complete Remission after Fertility-Sparing Therapy with Progestin

Positive peritoneal cytology at interval surgery is a poor prognostic factor in patients with stage T3c advanced ovarian carcinoma: A retrospective study

Putative tumor suppression function of SIRT6 in endometrial cancer

Radical hysterectomy with or without para-aortic lymphadenectomy for patients with stage IB2, IIA2, and IIB cervical cancer: outcomes for a series of 308 patients

Recent advances in targeting DNA repair pathways for the treatment of ovarian cancer and their clinical relevance

Regulation of SIRT1 determines initial step of endometrial receptivity by controlling E-cadherin expression

Repression of estrogen receptor beta function by putative tumor suppressor DBC1

Sequential effects of the proteasome inhibitor bortezomib and chemotherapeutic agents in uterine cervical cancer cell lines

The Emerging Role of FOXL2 in Regulating the Transcriptional Activation Function of Estrogen Receptor β: An Insight Into Ovarian Folliculogenesis.

The anti-malarial chloroquine suppresses proliferation and overcomes cisplatin resistance of endometrial cancer cells via autophagy inhibition.

The histone methyltransferase SMYD2 is a novel therapeutic target for the induction of apoptosis in ovarian clear cell carcinoma cells

The histone methyltransferase WHSC1 is regulated by EZH2 and is important for ovarian clear cell carcinoma cell proliferation

Usefulness of biopsy by office hysteroscopy for endometrial cancer: A case report

Usefulness of cell-free and concentrated ascites reinfusion therapy in the therapeutic management of advanced ovarian cancer patients with massive ascites